Skip to main content
Vicky (Li) Lee, MD, Oncology, Portland, OR, Good Samaritan Regional Medical Center

VickyH(Li)LeeMD

Oncology • Portland, OR

Physician

Join to view full profile

Dr. Lee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lee's full profile

Already have an account?

Summary

  • Dr. Vicky Lee is an oncologist in Adair Village, OR and is affiliated with multiple hospitals in the area, including Good Samaritan Regional Medical Center, Samaritan Albany General Hospital, and OHSU Hospital. She received her medical degree from Shandong Medical University and has been in practice 32 years. She specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma.

Education & Training

  • Zucker School of Medicine at Hofstra/Northwell
    Zucker School of Medicine at Hofstra/NorthwellFellowship, Hematology and Medical Oncology, 2002 - 2005
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1999 - 2002
  • Shandong Medical University
    Shandong Medical UniversityClass of 1985

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2005 - 2025
  • WA State Medical License
    WA State Medical License 2007 - 2025
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Press Mentions

  • Regencell Bioscience Holdings Limited Announces Partial Exercise of Underwriter’s over-Allotment Option
    Regencell Bioscience Holdings Limited Announces Partial Exercise of Underwriter’s over-Allotment OptionAugust 20th, 2021
  • Regencell Bioscience Holdings Limited Releases CEO Letter to Shareholders
    Regencell Bioscience Holdings Limited Releases CEO Letter to ShareholdersAugust 5th, 2021
  • Regencell Bioscience Holdings Limited宣佈約2,190萬美元的首次公開發行定價
    Regencell Bioscience Holdings Limited宣佈約2,190萬美元的首次公開發行定價July 20th, 2021
  • Join now to see all

Professional Memberships

Hospital Affiliations

Dr. Vicky Lee, Dr. Vicky Lee, MD, Dr. V Lee, Dr. Vicky H Lee